Corrigendum to: Intrathecal idursulfase-IT in patients with neuronopathic mucopolysaccharidosis II: Results from a phase 2/3 randomized study (Molecular Genetics and Metabolism (2022) 137(1–2) (127–139), (S1096719222003845), (10.1016/j.ymgme.2022.07.017))
Research output: Contribution to journal › Comment/debate › peer-review
Fingerprint
Dive into the research topics of 'Corrigendum to: Intrathecal idursulfase-IT in patients with neuronopathic mucopolysaccharidosis II: Results from a phase 2/3 randomized study (Molecular Genetics and Metabolism (2022) 137(1–2) (127–139), (S1096719222003845), (10.1016/j.ymgme.2022.07.017))'. Together they form a unique fingerprint.